Gender differences in risk factors for coronary heart disease

被引:79
作者
Tan, Yen Y. [1 ]
Gast, Gerrie-Cor M. [1 ]
van der Schouw, Yvonne T. [1 ]
机构
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
关键词
Gender; Risk factors; Coronary heart disease; POLYCYSTIC-OVARY-SYNDROME; ORAL-CONTRACEPTIVE USE; HORMONE REPLACEMENT THERAPY; ACUTE MYOCARDIAL-INFARCTION; ESTROGEN PLUS PROGESTIN; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; NATURAL MENOPAUSE; FOLLOW-UP; DIABETES-MELLITUS;
D O I
10.1016/j.maturitas.2009.09.023
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Coronary heart disease (CND), traditionally considered a male disease, is also a major threat to women. This review article addresses independent risk factors for CHD that are specific for women as well as non-gender-specific risk factors and how their effects differ between men and women. Although polycystic ovary syndrome (PCOS) in women is associated with an adverse metabolic risk profile, current evidence regarding future risk of CHD is conflicting. Preeclampsia is consistently associated with higher risk of CHD later in life. Menopause is associated with an increased risk of CHD, and the earlier the onset of menopause, the larger the risk. Existing data on postmenopausal hormone therapy (HT) was inconclusive with regard to possible protection when HT is initiated close to menopause in young peri- or postmenopausal women. Evidence on use of low-dose oral contraceptives strongly suggests no increased risk of CHD. Although levels of physical inactivity are similar for men and women, the higher prevalences of hypertension, diabetes, and obesity in older women portends a greater risk in women than in men. Additionally, risk factors like smoking, hypertriglyceridemia and low high-density lipoprotein cholesterol levels have greater impact in women than in men. This review indicates that acknowledgement of non-gender-specific risk factors in addition to those that are unique to women would help optimize diagnosis, treatment and earlier prevention of CHD in women. Further research is needed to ascertain if incorporating these gender-specific risks into a clinically used risk stratification model would change outcome in women. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:149 / 160
页数:12
相关论文
共 72 条
[51]   Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study [J].
Ray, JG ;
Vermeulen, MJ ;
Schull, MJ ;
Redelmeier, DA .
LANCET, 2005, 366 (9499) :1797-1803
[52]   MEDICAL PROGRESS - THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE IN WOMEN [J].
RICHEDWARDS, JW ;
MANSON, JE ;
HENNEKENS, CH ;
BURING, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (26) :1758-1766
[53]   Low-dose oral contraceptive use and the risk of myocardial infarction [J].
Rosenberg, L ;
Palmer, JR ;
Rao, RS ;
Shapiro, S .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (08) :1065-1070
[54]   Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause [J].
Rossouw, Jacques E. ;
Prentice, Ross L. ;
Manson, Joann E. ;
Wu, LieLing ;
Barad, David ;
Barnabei, Vanessa M. ;
Ko, Marcia ;
LaCroix, Andrea Z. ;
Margolis, Karen L. ;
Stefanick, Marcia L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13) :1465-1477
[55]   Brief report: Coronary heart disease events associated with hormone therapy in younger and older women [J].
Salpeter, SR ;
Walsh, JME ;
Greyber, E ;
Salpeter, EE .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (04) :363-366
[56]   RETRACTED: Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National heart, lung, and blood institute sponsored women's ischemia syndrome evaluation (Retracted Article) [J].
Shaw, Leslee J. ;
Merz, C. Noel Bairey ;
Azziz, Ricardo ;
Stanczyk, Frank Z. ;
Sopko, George ;
Braunstein, Glenn D. ;
Kelsey, Sheryl F. ;
Kip, Kevin E. ;
Cooper-DeHoff, Rhonda M. ;
Johnson, B. Delia ;
Vaccarino, Viola ;
Reis, Steven E. ;
Bittner, Vera ;
Hodgson, T. Keta ;
Rogers, William ;
Pepine, Carl J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) :1276-1284
[57]   Contraceptive Hormone Use and Cardiovascular Disease [J].
Shufelt, Chrisandra L. ;
Merz, C. Noel Bairey .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (03) :221-231
[58]   Myocardial infarction and use of low-dose oral contraceptives - A pooled analysis of 2 US studies [J].
Sidney, S ;
Siscovick, DS ;
Petitti, DB ;
Schwartz, SM ;
Quesenberry, CP ;
Psaty, BM ;
Raghunathan, TE ;
Kelaghan, J ;
Koepsell, TD .
CIRCULATION, 1998, 98 (11) :1058-1063
[59]   Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births [J].
Smith, GCS ;
Pell, JP ;
Walsh, D .
LANCET, 2001, 357 (9273) :2002-2006
[60]   Menstrual cycle irregularity and risk for future cardiovascular disease [J].
Solomon, CG ;
Hu, FB ;
Dunaif, A ;
Rich-Edwards, JE ;
Stampfer, MJ ;
Willett, WC ;
Speizer, FE ;
Manson, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2013-2017